Effect of Sammoha loha in Kamala (Jaundice) with special reference to increased Bilirubin level.

An Open Label Active Controlled Randomised Clinical Study To Evaluate The Efficacy Of Sammoha Loha In Kosthashrita Kamala With Special Reference To Hyperbilirubenemia

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/02/023168

Enrollment

Registered

2020-02-06

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K759- Inflammatory liver disease, unspecified

Interventions

Intervention1: Sammoha Loha: 500 mg twice daily before food with lukewarm water for maximum 30 days(or till the cessation of symptoms which ever is earlier). Control Intervention1: Arogyavardhini Vati

Eligibility

Inclusion criteria

Inclusion criteria: 1 Haridranetra (Yellowish discoloration of eye) 2 Haridratwaka (Yellowish discoloration of skin) 3 Haridranakha (Yellowish discoloration of nails) 4 Haridramukha (Yellowish discoloration of muth) 5 Raktapitta mutra and purish (Yellowish and reddish discoloration of urine & stool) 6 Bhekvarna (Skin colour like Frogâ??s colour) 7 Aruchi (Anorexia) 8 Daha (Burning sensation) 9 Avipaka (Indigestion) 10 Daurbalya (Weakness) 11 Sadana (Lassitude) 12 Patient having raised Sr. Bilirubin level till 5mg per dl.

Exclusion criteria

Exclusion criteria: 1 Patient associated with other known critical condition Such as Cardiovascular disease, Tuberculosis, AIDS etc. 2 Jaundice patient with Liver failure, Ascites, Liver cirrhosis and Biliary cirrhosis. 3 Jaundice due to genetical and chromosomal disorder. 4 Pregnant and Lactating women with Jaundice.

Design outcomes

Primary

Measure	Time frame
Changes in liver function test before and after studyTimepoint: At baseline and at the end of 30 days	—

Secondary

Measure	Time frame
Changes in symptoms of Koshthashrita Kamala on the basis of gradesTimepoint: At baseline and at the end of 7th, 15th, 21st and 30th day	—

Countries

India

Contacts

Public ContactDr Ajay Paghdal

Parul Institute Of Ayurved

drshaileshd@gmail.com9763104451

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026